Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

The first integrated proteomic and lipidomic profiling reveals immune, metabolic, and membrane remodeling signatures in patients experiencing cytokine release storm (CRS) undergoing CAR-T cell therapy and serves as a new predictive and prognostic factor.

Kannathasan Thetchinamoorthy, Diana Wierzbicka, Jaromir Tomasik, Grzegorz Basak, Mariusz Z Ratajczak, Magdalena Kucia

Blood (2025) 146 (Supplement 1): 3557.

https://doi.org/10.1182/blood-2025-3557

Published: 2025

Journal Articles

New evidence that complement activation and NLRP3 inflammasome signaling work together to cause cytokine release syndrome after CAR-T cell therapy

Diana Wierzbicka, Kannathasan Thetchinamoorthy, Jaromir Tomasik, Mariusz Z Ratajczak, Magdalena Kucia

Blood (2025) 146 (Supplement 1): 2328.

https://doi.org/10.1182/blood-2025-2328

Published: 2025

Journal Articles

Unsupervised proteomic and metabolomic longitudinal serum profiling of anti-CD19 CAR-T cell therapy recipients reveals clinically distinct groups

Jaromir Tomasik, Kannathasan Thetchinamoorthy, Diana Wierzbicka, Agnieszka Tomaszewska, Piotr Kacprzyk, Joanna Drozd-Sokołowska, Rafał Machowicz, Mariusz Ratajczak, Magdalena Kucia, Grzegorz Basak

Blood (2025) 146 (Supplement 1): 5926.

https://doi.org/10.1182/blood-2025-5926

Published: 2025

Journal Articles

The Pro-Mobilizing Effects of UDP-Glucose-P2Y14 Purinergic Receptor Signaling Are Explained By Promoting Membrane Lipid Raft Formation to Optimize Hspcs' Responsiveness to Chemoattractants-a Potential Strategy to Optimize Hematopoietic Transplantation and Improve Transplant Outcomes

Kamila Bujko, Mateusz Admiak, Kannathasan Thetchinamoorthy, Arjun Thapa, Diana Wierzbicka, Magdalena Molenda, Mariusz Z Ratajczak, Magdalena Kucia

Blood (2024) 144 (Supplement 1): 4034.

https://doi.org/10.1182/blood-2024-204825

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

The first integrated proteomic and lipidomic profiling reveals immune, metabolic, and membrane remodeling signatures in patients experiencing cytokine release storm (CRS) undergoing CAR-T cell therapy and serves as a new predictive and prognostic factor.

New evidence that complement activation and NLRP3 inflammasome signaling work together to cause cytokine release syndrome after CAR-T cell therapy

Unsupervised proteomic and metabolomic longitudinal serum profiling of anti-CD19 CAR-T cell therapy recipients reveals clinically distinct groups

The Pro-Mobilizing Effects of UDP-Glucose-P2Y14 Purinergic Receptor Signaling Are Explained By Promoting Membrane Lipid Raft Formation to Optimize Hspcs' Responsiveness to Chemoattractants-a Potential Strategy to Optimize Hematopoietic Transplantation and Improve Transplant Outcomes

Email alerts

ASH Publications

American Society of Hematology

Update search

The first integrated proteomic and lipidomic profiling reveals immune, metabolic, and membrane remodeling signatures in patients experiencing cytokine release storm (CRS) undergoing CAR-T cell therapy and serves as a new predictive and prognostic factor.

New evidence that complement activation and NLRP3 inflammasome signaling work together to cause cytokine release syndrome after CAR-T cell therapy

Unsupervised proteomic and metabolomic longitudinal serum profiling of anti-CD19 CAR-T cell therapy recipients reveals clinically distinct groups

The Pro-Mobilizing Effects of UDP-Glucose-P2Y14 Purinergic Receptor Signaling Are Explained By Promoting Membrane Lipid Raft Formation to Optimize Hspcs' Responsiveness to Chemoattractants-a Potential Strategy to Optimize Hematopoietic Transplantation and Improve Transplant Outcomes

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only